Ipilimumab 60-month Pharmacovigilance Protocol for Advanced Melanoma Patients Who Are Hepatitis B and/or Hepatitis C Virus Positive in Taiwan
NCT02402699
·
clinicaltrials.gov ↗
COMPLETED
Status
3
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Melanoma
Hepatitis B
Hepatitis C
Sponsor
Bristol-Myers Squibb